Angus J.

Angus J. serves as Co-Founder and Chief Business Officer at Adventa Bioscience since September 2019, where responsibilities include overseeing product management, development, grant applications, and regulatory aspects, contributing to the market launch of the flagship product Trulacta. Additionally, Angus holds roles as Treasurer and Secretary of the Board of Directors at CAV Angels, a venture investment group focused on UVA-affiliated startups, and as Director of New Ventures at Attwill Medical Solutions, leading investment opportunities in the life sciences sector. Previous experience includes positions such as Secretary of the Board of Directors for the Duke Angel Network, various legal roles, and internships in M&A. Angus J. holds an MBA from the University of Virginia Darden School of Business and advanced degrees in law from Duke University and the University of Georgia.